Saturday 17 October 2026
Export SINT’s income statement to Excel — free account
SINTX TECHNOLOGIES, INC.
SINT Healthcare Medical Devices
SINTX TECHNOLOGIES, INC.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, down 64.7% from fiscal 2024. In the quarter to June 2026, revenue grew 199.3%, EPS grew 17.6%, free cash flow fell 38.6% and total debt fell 6.42%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.74
0.03
−1.69%
Follow SINT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | — | — | — | 3 | 2 | 4 | 4 | 5 | 2 |
Altman Z-Score |
279,646.58 | — | — | (37.42) | (7.77) | (14.96) | (25.46) | (27.03) | (45.92) | (45.42) |
P/S ratio |
472,387.34 | — | 0.00 | 4.33 | 42.29 | 25.43 | 1.85 | 0.55 | 0.90 | 10.52 |
Altman Z″-Score (non-manufacturers) |
(27.90) | — | (67.09) | (85.45) | (16.53) | (33.07) | (58.84) | (60.76) | (105.09) | (105.96) |
P/FCF ratio |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(3,759,837.74) | — | 0.00 | (1.92) | (12.22) | (6.47) | (1.38) | (0.46) | (2.31) | (4.57) |
Beneish M-Score |
(4.20) | — | — | 3.88 | (3.06) | (0.90) | (1.96) | 0.78 | (4.22) | (3.03) |
P/B ratio |
640,193.11 | — | 0.00 | 0.57 | 0.97 | 0.90 | 0.50 | 0.17 | 0.67 | 3.66 |
Price to Tangible BV |
3,815,686.79 | — | 0.00 | 0.58 | 0.97 | 0.90 | 0.51 | 0.17 | 0.67 | 4.31 |
EV/Sales |
472,387.35 | — | (0.41) | 1.76 | 0.28 | 5.84 | (1.82) | (0.70) | (0.33) | 6.47 |
EV/EBITDA |
0.00 | — | 0.40 | 0.00 | 0.00 | 0.00 | 0.27 | 0.16 | 0.08 | 0.00 |
EV/Operating CF |
(1,003,147.80) | — | 0.56 | (0.19) | (0.02) | (0.35) | 0.28 | 0.13 | 0.11 | (0.77) |
EV/FCF |
(923,663.76) | — | 0.59 | (0.19) | (0.02) | (0.26) | 0.24 | 0.13 | 0.10 | (0.78) |
Quick Ratio |
0.61 | 0.22 | 2.40 | 0.93 | 8.82 | 5.23 | 0.81 | 1.39 | 1.91 | 1.16 |
Current Ratio |
1.14 | 0.44 | 2.95 | 1.97 | 9.58 | 5.47 | 0.89 | 1.90 | 2.28 | 1.51 |
Net Debt/EBITDA |
(0.01) | (0.01) | 0.41 | 0.29 | 3.12 | 1.19 | 0.55 | 0.28 | 0.28 | 0.41 |
Debt/Assets |
26.70% | 4.13% | 1.47% | 0.20% | 1.30% | 11.02% | 3.35% | 0.30% | 0.34% | 0.07% |
Debt/Equity |
0.62 | 0.11 | 0.02 | 0.00 | 0.02 | 0.14 | 0.09 | 0.01 | 0.01 | 0.00 |
Asset Turnover |
0.49 | 0.00 | 0.01 | 0.07 | 0.03 | 0.02 | 0.08 | 0.17 | 0.23 | 0.11 |
Operating CF/Net income |
0.34 | 0.50 | 0.41 | 0.86 | 0.55 | 1.09 | 0.62 | 1.70 | 0.78 | 0.50 |
Capex/Depreciation |
(0.32) | (0.05) | (0.56) | (0.31) | (0.72) | (5.54) | (1.46) | (0.30) | (0.48) | 0.25 |
Interest Coverage |
(2.56) | (5.93) | (9.45) | (1,648.50) | (4,252.00) | (424.80) | (666.76) | (6,679.00) | (484.38) | (206.17) |
| (165.24%) | (111.88%) | (325.87%) | (110.29%) | (107.04%) | (43.30%) | (144.02%) | (114.47%) | (174.07%) | (500.75%) | |
| (67.74%) | (45.62%) | (172.44%) | (72.60%) | (83.82%) | (35.61%) | (87.68%) | (53.21%) | (88.98%) | (180.59%) | |
ROIC |
(63.62%) | (84.93%) | (262.66%) | (120.05%) | (626.03%) | (124.55%) | 0.00% | (152.41%) | (2,676.64%) | 0.00% |
Return on Tangible Assets |
(729.07%) | 212.89% | (473.68%) | (342.94%) | (65.90%) | (57.09%) | (341.95%) | (111.18%) | (318.52%) | (713.87%) |
Average Days of Receivables |
38.83 | 0.00 | 1,010.47 | 72.05 | 25.19 | 61.44 | 76.69 | 95.18 | 24.78 | 63.82 |
Research and Development Expense of Revenue |
41.67% | 0.00% | 3,148.42% | 492.60% | 809.43% | 971.29% | 413.20% | 331.67% | 180.15% | 450.59% |
Selling, General and Administrative Expense of Revenue |
109.28% | 0.00% | 4,211.58% | 484.47% | 642.26% | 807.10% | 341.19% | 204.00% | 159.72% | 632.51% |
Intangible Assets out of Total Assets |
0.36 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
Share Based Compensation of Revenue |
1.79% | 0.00% | 44.21% | 0.29% | 7.58% | 50.99% | 23.64% | 11.08% | 2.84% | 196.07% |
Graham Net Nets |
0.00 | — | 0.00 | 0.04 | 0.91 | 0.67 | (0.99) | (0.73) | (0.38) | (0.09) |
Graham Number |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(86.67%) | — | (2,033.41%) | (424.97%) | (126.95%) | (58.87%) | (420.87%) | (524.55%) | (417.28%) | (155.32%) |
Free Cash Flow Yield |
0.00% | — | 0.00% | (218.09%) | (37.91%) | (89.41%) | (406.84%) | (1,013.28%) | (360.83%) | (79.00%) |
Revenue per Share |
9.86 | 0.00 | 0.00 | 6,890.00 | 742.50 | 505.00 | 1,040.67 | 140.48 | 3.89 | 0.37 |
Operating CF per Share |
(4.64) | (1.57) | 0.00 | (64,350.00) | (11,390.00) | (8,439.17) | (6,842.00) | (754.81) | (11.66) | (3.09) |
Capex per Share |
(0.40) | 0.00 | 0.00 | (1,470.00) | (450.00) | (3,000.00) | (936.00) | (26.79) | (0.90) | 0.06 |
Free Cash Flow per Share |
(5.04) | (1.57) | 0.00 | (65,820.00) | (11,840.00) | (11,439.17) | (7,778.00) | (781.60) | (12.56) | (3.03) |
Cash per Share |
4.48 | 0.18 | 0.00 | 17,870.00 | 31,688.75 | 11,894.17 | 4,163.33 | 178.61 | 4.85 | 1.49 |
Shareholders Equity per Share |
7.28 | 1.83 | 0.00 | 52,020.00 | 32,255.00 | 14,329.17 | 3,802.67 | 469.09 | 5.25 | 1.06 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.28 | 1.83 | 0.00 | 52,020.00 | 32,255.00 | 14,329.17 | 3,802.67 | 469.09 | 5.25 | 1.06 |
Free Cash Flow |
(7.79) | (4.69) | (9.41) | (6.58) | (9.47) | (13.73) | (11.67) | (14.62) | (9.31) | (8.41) |
Working Capital |
2.00 | (4.60) | 4.64 | 2.00 | 24.71 | 12.28 | (0.87) | 2.63 | 2.54 | 1.92 |
Capital Expenditures |
(0.62) | (0.01) | (0.06) | (0.15) | (0.36) | (3.60) | (1.40) | (0.50) | (0.67) | 0.16 |
Net Current Asset Value |
0.96 | (5.53) | 3.90 | 0.12 | 22.95 | 10.38 | (2.86) | (1.06) | (1.00) | (0.93) |
EV/EBIT |
0.00 | — | 0.40 | 0.00 | 0.00 | 0.00 | 0.25 | 0.14 | 0.07 | 0.00 |
Capex to Sales |
0.04 | 0.00 | 0.64 | 0.21 | 0.61 | 5.94 | 0.90 | 0.19 | 0.23 | (0.16) |
Price to Operating Income |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.20 | 0.57 | 0.88 | 2.47 | 1.06 | 0.16 | 0.17 | 0.34 | 1.50 | 1.39 |
Cash ROIC |
(30.95%) | (71.15%) | (67.14%) | (93.93%) | (18.37%) | (40.52%) | (93.51%) | (120.22%) | (123.76%) | (118.82%) |
Accounts Receivable Turnover |
7.12 | 0.00 | 0.13 | 3.45 | 6.71 | 8.48 | 7.26 | 5.19 | 6.55 | 5.44 |
Accounts Payable Turnover |
5.81 | 0.09 | 0.06 | 2.24 | 2.47 | 2.06 | 0.79 | 1.47 | 1.73 | 1.64 |
Inventory Turnover |
0.46 | 0.03 | 0.66 | 6.97 | 4.63 | 2.23 | 0.90 | 1.34 | 1.17 | 0.84 |
Average Days of Payables |
63.59 | 6,020.76 | 1,961.88 | 126.52 | 149.07 | 195.91 | 597.77 | 296.10 | 134.57 | 250.32 |
Days of Inventory on Hand |
697.05 | 406.71 | 338.93 | 70.22 | 76.07 | 246.31 | 391.17 | 413.42 | 225.93 | 540.62 |
Average Receivables |
2.14 | 1.43 | 0.75 | 0.20 | 0.09 | 0.07 | 0.22 | 0.51 | 0.44 | 0.19 |
Average Payables |
0.65 | 1.20 | 1.02 | 0.25 | 0.19 | 0.22 | 0.34 | 0.54 | 0.47 | 0.34 |
Average Inventory |
8.17 | 3.67 | 0.08 | 0.08 | 0.10 | 0.20 | 0.29 | 0.59 | 0.70 | 0.66 |
Average Assets |
31.06 | 20.45 | 13.08 | 10.33 | 19.80 | 26.14 | 18.81 | 15.57 | 12.39 | 9.46 |
Average Common Equity |
12.73 | 8.34 | 6.92 | 6.80 | 15.50 | 21.50 | 11.45 | 7.24 | 6.33 | 3.41 |
Columns are period end dates